AAAAAA
Results: 1-25/26
Authors:
KATO N
SHIGETA Y
TANAKA W
HASEGAWA H
Citation: N. Kato et al., SEMANTIC VERIFICATION AND SATISFIABILITY VERIFICATION OF MSC SPECIFICATIONS BY MEANS OF PETRI NETS IN TELECOMMUNICATION SOFTWARE TESTING, Electronics and communications in Japan. Part 3, Fundamental electronic science, 81(10), 1998, pp. 58-72
Authors:
YAMANAKA N
TANAKA T
TANAKA W
YAMANAKA J
YASUI C
ANDO T
TAKADA M
MAEDA S
OKAMOTO E
Citation: N. Yamanaka et al., LAPAROSCOPIC PARTIAL-HEPATECTOMY, Hepato-gastroenterology, 45(19), 1998, pp. 29-33
Authors:
TANAKA W
FLYNN M
SHARMA D
PITT B
BENEDICT C
GOLDBERG A
DUNLAY M
VELIVIS M
GERTZ B
Citation: W. Tanaka et al., PLASMA ANGIOTENSIN-II (AII) LEVELS IN HEART-FAILURE PATIENTS - EFFECTOF LOSARTAN (L) ADDED TO ENALAPRIL (E), Clinical pharmacology and therapeutics, 63(2), 1998, pp. 20-20
Authors:
YAMANAKA N
FURUKAWA K
TANAKA T
TANAKA W
YAMANAKA J
IMAKITA M
OKAMOTO E
Citation: N. Yamanaka et al., TOPICAL COOLING-ASSISTED HEPATIC SEGMENTECTOMY FOR CIRRHOTIC LIVER WITH HEPATOCELLULAR-CARCINOMA, Journal of the American College of Surgeons, 184(3), 1997, pp. 290-296
Authors:
FUJIMOTO J
OKAMOTO E
YAMANAKA N
TANAKA T
TANAKA W
Citation: J. Fujimoto et al., ADVERSE EFFECT OF PERIOPERATIVE BLOOD-TRANSFUSIONS ON SURVIVAL AFTER HEPATIC RESECTION FOR HEPATOCELLULAR-CARCINOMA, Hepato-gastroenterology, 44(17), 1997, pp. 1390-1396
Authors:
IIZUMI T
IIYAMA T
TANAKA W
OKADA E
KAMIYAMA Y
OKANO Y
SATO S
YAZAKI T
UMEDA T
IMAMURA T
Citation: T. Iizumi et al., IMMUNOHISTOCHEMICAL STUDIES OF PROLIFERATING CELL NUCLEAR ANTIGEN ANDCATHEPSIN-D IN TRANSITIONAL-CELL CARCINOMA OF THE URINARY-BLADDER, Urologia internationalis, 59(2), 1997, pp. 81-87
Authors:
YAMANAKA N
TAKAYA Y
ORIYAMA T
FURUKAWA K
TANAKA T
TANAKA W
ICHIKAWA N
YASUI C
ANDO T
YAMANAKA J
KURODA N
KO M
TAKADA M
IMAKITA M
KITAYAMA Y
OKAMOTO E
SASAKI S
NAKAGAKI I
HORI S
ITO T
Citation: N. Yamanaka et al., HEPATOPROTECTIVE EFFECT OF A NONSELECTIVE ENDOTHELIN RECEPTOR ANTAGONIST (TAK-044) IN THE TRANSPLANTED LIVER, The Journal of surgical research, 70(2), 1997, pp. 156-160
Authors:
YAMANAKA N
TANAKA T
TANAKA W
YAMANAKA J
YASUI C
KURODA N
TAKADA M
OKAMOTO E
Citation: N. Yamanaka et al., CORRELATION OF HEPATITIS-VIRUS SEROLOGIC STATUS WITH CLINICOPATHOLOGICAL FEATURES IN PATIENTS UNDERGOING HEPATECTOMY FOR HEPATOCELLULAR-CARCINOMA, Cancer, 79(8), 1997, pp. 1509-1515
Authors:
TANAKA W
SARKISSIAN G
KATO H
OHBATA N
KOSE Y
Citation: W. Tanaka et al., HIGH-POWER LINEAR SILICON MOSFET FOR 820-APPROXIMATE-TO-960 MHZ BASE STATION APPLICATION, NEC research & development, 37(1), 1996, pp. 8-12
Authors:
YAMANAKA N
TANAKA T
ORIYAMA T
FURUKAWA K
TANAKA W
OKAMOTO E
Citation: N. Yamanaka et al., MICROWAVE COAGULONECROTIC THERAPY FOR HEPATOCELLULAR-CARCINOMA, World journal of surgery, 20(8), 1996, pp. 1076-1081
Authors:
SCHWARTZ J
GERTZ B
TANAKA W
WANG D
WINCHELL G
ADCOCK S
EBEL D
FLYNN M
CONSTANZER M
Citation: J. Schwartz et al., TOPICAL MK-386 (M), AN INHIBITOR OF 5-ALPHA-REDUCTASE (5-ALPHA-R) TYPE-1, SUPPRESSES SEBUM DHT, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 32-32
Authors:
EHRICH E
DALLOB A
VANHECKEN A
DEPRE M
DELEPELEIRE I
BRIDEAU C
HILLIARD D
TANAKA W
MUKHOPADHYAY S
SEIBOLD J
DESCHEPPER P
GERTZ B
Citation: E. Ehrich et al., DEMONSTRATION OF SELECTIVE COX-2 INHIBITION BY MK-966 IN HUMANS, Arthritis and rheumatism, 39(9), 1996, pp. 328-328
Authors:
UEMATSU T
KANAMARU M
KOSUGE K
HARA K
UCHIYAMA U
TAKENAGA N
TANAKA W
FRIEDMAN BS
NAKASHIMA M
Citation: T. Uematsu et al., PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF A NOVEL LEUKOTRIENE BIOSYNTHESIS INHIBITOR, MK-0591, IN HEALTHY-VOLUNTEERS, British journal of clinical pharmacology, 40(1), 1995, pp. 59-66
Authors:
YAMANAKA N
OKAMOTO E
FURUKAWA K
ORIYAMA T
FUJIMOTO J
KANNO H
KAWAMURA E
TANAKA T
TOMODA H
ICHIKAWA N
TANAKA W
YASUI T
Citation: N. Yamanaka et al., HEPATIC RESECTION UNDER IN-SITU HEMIHEPATIC HYPOTHERMIC PERFUSION WITH HEPATOPROTECTIVE AGENTS, Hepato-gastroenterology, 42(1), 1995, pp. 1-4
Authors:
CONNOR J
KEILANI T
SEGAL R
WINCHELL G
TANAKA W
SWITHENBANK R
LEVINE B
BATLLE D
Citation: J. Connor et al., PHARMACOKINETICS AND SAFETY OF DORZOLAMIDE (MK-507) IN PATIENTS WITH MODERATE RENAL IMPAIRMENT, Investigative ophthalmology & visual science, 36(4), 1995, pp. 738-738
Authors:
ADAMSONS I
CONNOR J
STROHMAIER K
TANAKA W
CONSTANZER M
KUSMA S
WINCHELL G
Citation: I. Adamsons et al., SYSTEMIC PHARMACOKINETICS AND CARBONIC-ANHYDRASE INHIBITION OF DORZOLAMIDE, Vision research, 35, 1995, pp. 2135-2135
Authors:
YAMANAKA N
OKAMOTO E
ANDO T
ORIYAMA T
FUJIMOTO J
FURUKAWA K
TANAKA T
TANAKA W
NISHIGAMI T
Citation: N. Yamanaka et al., CLINICOPATHOLOGICAL SPECTRUM OF RESECTED EXTRADUCTAL MASS-FORMING INTRAHEPATIC CHOLANGIOCARCINOMA, Cancer, 76(12), 1995, pp. 2449-2456
Authors:
KASUYA A
TANAKA W
NISHITANI R
SAITO Y
SHINOHARA H
NISHINA Y
Citation: A. Kasuya et al., RAMAN-SCATTERING STUDY ON A PURE C-60 FILM IN VACUUM, JPN J A P 2, 34, 1994, pp. 200-202
Authors:
SASAKI T
CHIKADA Y
OGASAWARA R
ICHIKAWA S
TANAKA W
NOGUCHI T
OKITA K
Citation: T. Sasaki et al., CONCEPT DESIGN OF A CONTROL-SYSTEM FOR THE SUBARU TELESCOPE, Nuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment, 352(1-2), 1994, pp. 75-78
Authors:
AOYAGI Y
TANAKA W
OHTA A
Citation: Y. Aoyagi et al., LOW-VALENT TANTALUM-MEDIATED REACTION, Journal of the Chemical Society, Chemical Communications, (10), 1994, pp. 1225-1226
Authors:
DEPRE M
FRIEDMAN B
VANHECKEN A
DELEPELEIRE I
TANAKA W
DALLOB A
SHINGO S
PORRAS A
LIN C
DESCHEPPER PJ
Citation: M. Depre et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF MULTIPLE ORAL DOSES OF MK-0591, A 5-LIPOXYGENASE-ACTIVATING PROTEIN INHIBITOR, Clinical pharmacology and therapeutics, 56(1), 1994, pp. 22-30
Authors:
CHIKUMA T
TANAKA W
YAMADA K
ISHII Y
TANAKA A
KATO T
Citation: T. Chikuma et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF PZ-PEPTIDASEACTIVITY, Journal of chromatography, 635(1), 1993, pp. 81-87
Authors:
YAMANAKA N
OKAMOTO E
KAWAMURA E
KATO T
ORIYAMA T
FUJIMOTO J
FURUKAWA K
TANAKA T
TOMODA F
TANAKA W
Citation: N. Yamanaka et al., DYNAMICS OF NORMAL AND INJURED HUMAN LIVER-REGENERATION AFTER HEPATECTOMY AS ASSESSED ON THE BASIS OF COMPUTED-TOMOGRAPHY AND LIVER-FUNCTION, Hepatology, 18(1), 1993, pp. 79-85
Authors:
GOLDBERG MR
TANAKA W
BARCHOWSKY A
BRADSTREET TE
MCCREA J
LO MW
MCWILLIAMS EJ
BJORNSSON TD
Citation: Mr. Goldberg et al., EFFECTS OF LOSARTAN ON BLOOD-PRESSURE, PLASMA-RENIN ACTIVITY, AND ANGIOTENSIN-II IN VOLUNTEERS, Hypertension, 21(5), 1993, pp. 704-713
Authors:
DEPRE M
FRIEDMAN B
TANAKA W
VANHECKEN A
BUNTINX A
DESCHEPPER PJ
Citation: M. Depre et al., BIOCHEMICAL-ACTIVITY, PHARMACOKINETICS, AND TOLERABILITY OF MK-886, ALEUKOTRIENE BIOSYNTHESIS INHIBITOR, IN HUMANS, Clinical pharmacology and therapeutics, 53(5), 1993, pp. 602-607